Surrogate Markers and Clinical Outcomes-Reply

JAMA. 2024 Sep 17;332(11):936-937. doi: 10.1001/jama.2024.14279.
No abstract available

Publication types

  • Letter
  • Research Support, U.S. Gov't, P.H.S.
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Biomarkers / blood
  • Chronic Disease / drug therapy
  • Gout Suppressants / therapeutic use
  • Gout* / blood
  • Gout* / diagnosis
  • Gout* / drug therapy
  • Humans
  • Treatment Outcome
  • Uric Acid* / blood

Substances

  • Biomarkers
  • Gout Suppressants
  • Uric Acid